These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27877888)

  • 81. Cyclodextrin-Based Macromolecular Systems as Cholesterol-Mopping Therapeutic Agents in Niemann-Pick Disease Type C.
    Puglisi A; Yagci Y
    Macromol Rapid Commun; 2019 Jan; 40(1):e1800557. PubMed ID: 30216584
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Methyl-β-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK.
    Dai S; Dulcey AE; Hu X; Wassif CA; Porter FD; Austin CP; Ory DS; Marugan J; Zheng W
    Autophagy; 2017 Aug; 13(8):1435-1451. PubMed ID: 28613987
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease.
    Chen J; Soni RK; Xu Y; Simoes S; Liang FX; DeFreitas L; Hwang R; Montesinos J; Lee JH; Area-Gomez E; Nandakumar R; Vardarajan B; Marquer C
    EBioMedicine; 2023 Jun; 92():104628. PubMed ID: 37245481
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dynamics of lysosomal cholesterol in Niemann-Pick type C and normal human fibroblasts.
    Lange Y; Ye J; Rigney M; Steck TL
    J Lipid Res; 2002 Feb; 43(2):198-204. PubMed ID: 11861661
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin.
    Bergamin N; Dardis A; Beltrami A; Cesselli D; Rigo S; Zampieri S; Domenis R; Bembi B; Beltrami CA
    Orphanet J Rare Dis; 2013 Feb; 8():34. PubMed ID: 23433359
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann-Pick Type C Disease Model Mice.
    Nishida T; Yokoyama R; Kubohira Y; Maeda Y; Takeo T; Nakagata N; Takagi H; Ishikura K; Yanagihara K; Misumi S; Kishimoto N; Ishitsuka Y; Kondo Y; Irie T; Soga M; Era T; Onodera R; Higashi T; Motoyama K
    ACS Appl Bio Mater; 2022 May; 5(5):2377-2388. PubMed ID: 35506864
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.
    Pipalia NH; Cosner CC; Huang A; Chatterjee A; Bourbon P; Farley N; Helquist P; Wiest O; Maxfield FR
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5620-5. PubMed ID: 21436030
    [TBL] [Abstract][Full Text] [Related]  

  • 88. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
    Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
    FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease.
    Collins CJ; Loren BP; Alam MS; Mondjinou Y; Skulsky JL; Chaplain CR; Haldar K; Thompson DH
    Sci Rep; 2017 Apr; 7():46737. PubMed ID: 28452365
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Abnormal accumulation and recycling of glycoproteins visualized in Niemann-Pick type C cells using the chemical reporter strategy.
    Mbua NE; Flanagan-Steet H; Johnson S; Wolfert MA; Boons GJ; Steet R
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10207-12. PubMed ID: 23733943
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lamellar Bodies in Podocytes Associated With Compound Heterozygous Mutations for Niemann Pick Type C1 Mimicking Fabry Disease, a Case Report.
    Pintavorn P; Munie S; Munagapati S
    Can J Kidney Health Dis; 2022; 9():20543581221124635. PubMed ID: 36325261
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin.
    Vance JE; Peake KB
    Curr Opin Lipidol; 2011 Jun; 22(3):204-9. PubMed ID: 21412152
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Improvement in lipid and protein trafficking in Niemann-Pick C1 cells by correction of a secondary enzyme defect.
    Devlin C; Pipalia NH; Liao X; Schuchman EH; Maxfield FR; Tabas I
    Traffic; 2010 May; 11(5):601-15. PubMed ID: 20412078
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann-Pick Type C disease.
    Matsuo M; Shraishi K; Wada K; Ishitsuka Y; Doi H; Maeda M; Mizoguchi T; Eto J; Mochinaga S; Arima H; Irie T
    Mol Genet Metab Rep; 2014; 1():391-400. PubMed ID: 27896112
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
    Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
    Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Formation and degradation of layer-by-layer-assembled polyelectrolyte polyrotaxane capsules.
    Dam HH; Caruso F
    Langmuir; 2013 Jun; 29(24):7203-8. PubMed ID: 23368764
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cationic Polyrotaxanes as a Feasible Framework for the Intracellular Delivery and Sustainable Activity of Anionic Enzymes: A Comparison Study with Methacrylate-Based Polycations.
    Tamura A; Ikeda G; Nishida K; Yui N
    Macromol Biosci; 2015 Aug; 15(8):1134-45. PubMed ID: 25923376
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann-Pick type C disease-like HepG2 cells.
    Motoyama K; Hirai Y; Nishiyama R; Maeda Y; Higashi T; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
    Beilstein J Org Chem; 2015; 11():2079-86. PubMed ID: 26664628
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Efficacy and ototoxicity of different cyclodextrins in Niemann-Pick C disease.
    Davidson CD; Fishman YI; Puskás I; Szemán J; Sohajda T; McCauliff LA; Sikora J; Storch J; Vanier MT; Szente L; Walkley SU; Dobrenis K
    Ann Clin Transl Neurol; 2016 May; 3(5):366-80. PubMed ID: 27231706
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cyclodextrins-Based Polyrotaxanes: From Functional Polymers to Applications in Electronics and Energy Storage Materials.
    Du R; Bao T; Kong D; Zhang Q; Jia X
    Chempluschem; 2024 Jul; 89(7):e202300706. PubMed ID: 38567455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.